Security key
640268108
NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR)
CUSIP: 640268108
Q2 2017 13F Holders as of 30 Jun 2017
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 29,109,163
- Total 13F shares
- 151,352,082
- Share change
- +6,477,047
- Total reported value
- $2,959,589,678
- Put/Call ratio
- 27%
- Price per share
- $19.55
- Number of holders
- 196
- Value change
- +$123,309,771
- Number of buys
- 116
- Number of sells
- 71
Report period
Q2 2017
Institutions
196
Top holders
10
NKTR full security history
Newer quarter: Q3 2017
Previous quarter: Q1 2017
NEKTAR THERAPEUTICS SEC filings
NEKTAR THERAPEUTICS company facts
Broader feeds
Reporting periods
Holder history for CUSIP 640268108
Recent filing periods:
Top shareholders of NKTR - NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| OppenheimerFunds, Inc. |
13F
|
Company |
82%
|
24,010,818
|
$563,534,000 | — | 31 Mar 2017 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
74%
|
21,453,485
|
$503,513,000 | — | 31 Mar 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
69%
|
20,035,546
|
$470,234,000 | — | 31 Mar 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
47%
|
13,607,980
|
$319,379,000 | — | 31 Mar 2017 | |
| Camber Capital Management LP |
13F
|
Company |
19%
|
5,400,000
|
$126,738,000 | — | 31 Mar 2017 | |
| Invesco Ltd. |
13F
|
Company |
15%
|
4,260,455
|
$99,993,000 | — | 31 Mar 2017 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
14%
|
4,030,539
|
$94,597,000 | — | 31 Mar 2017 | |
| STATE STREET CORP |
13F
|
Company |
14%
|
3,961,247
|
$92,967,000 | — | 31 Mar 2017 | |
| BRIDGER MANAGEMENT, LLC |
13F
|
Company |
10%
|
2,937,255
|
$68,937,000 | — | 31 Mar 2017 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
9.6%
|
2,807,422
|
$65,891,000 | — | 31 Mar 2017 | |
| NORGES BANK |
13F
|
Company |
8.1%
|
2,352,325
|
$55,209,000 | — | 31 Mar 2017 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
7.7%
|
2,249,950
|
$52,806,000 | — | 31 Mar 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
7.3%
|
2,125,902
|
$49,895,000 | — | 31 Mar 2017 | |
| FMR LLC |
13F
|
Company |
6.7%
|
1,947,644
|
$45,711,000 | — | 31 Mar 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
6.2%
|
1,807,058
|
$42,410,000 | — | 31 Mar 2017 | |
| JANUS HENDERSON INVESTORS US LLC |
13F
|
Company |
5.9%
|
1,709,729
|
$40,125,000 | — | 31 Mar 2017 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
5.3%
|
1,529,892
|
$35,907,000 | — | 31 Mar 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
4.6%
|
1,340,104
|
$31,452,000 | — | 31 Mar 2017 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
4.4%
|
1,287,250
|
$30,212,000 | — | 31 Mar 2017 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
4%
|
1,158,340
|
$27,186,000 | — | 31 Mar 2017 | |
| ROTHSCHILD & CO ASSET MANAGEMENT US INC. |
13F
|
Company |
3.8%
|
1,101,445
|
$25,851,000 | — | 31 Mar 2017 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
3.7%
|
1,079,100
|
$25,326,000 | — | 31 Mar 2017 | |
| Marshall Wace North America L.P. |
13F
|
Company |
3.5%
|
1,025,218
|
$23,580,000 | — | 31 Mar 2017 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
3.5%
|
1,025,147
|
$24,060,000 | — | 31 Mar 2017 | |
| Artal Group S.A. |
13F
|
Company |
3.4%
|
1,000,000
|
$23,470,000 | — | 31 Mar 2017 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
3%
|
872,933
|
$20,489,000 | — | 31 Mar 2017 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
2.5%
|
735,117
|
$17,253,000 | — | 31 Mar 2017 | |
| SYSTEMATIC FINANCIAL MANAGEMENT LP |
13F
|
Company |
2.5%
|
726,653
|
$17,055,000 | — | 31 Mar 2017 | |
| Duquesne Family Office LLC |
13F
|
Company |
2.3%
|
665,600
|
$15,622,000 | — | 31 Mar 2017 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
2.3%
|
663,324
|
$15,568,000 | — | 31 Mar 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2.2%
|
643,437
|
$15,101,000 | — | 31 Mar 2017 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
2.2%
|
633,597
|
$14,871,000 | — | 31 Mar 2017 | |
| MORGAN STANLEY |
13F
|
Company |
2%
|
593,009
|
$13,917,000 | — | 31 Mar 2017 | |
| Granahan Investment Management, LLC |
13F
|
Company |
1.9%
|
562,473
|
$13,201,000 | — | 31 Mar 2017 | |
| Tamarack Advisers, LP |
13F
|
Company |
1.7%
|
500,000
|
$11,735,000 | — | 31 Mar 2017 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
1.6%
|
470,000
|
$11,031,000 | — | 31 Mar 2017 | |
| PDT Partners, LLC |
13F
|
Company |
1.6%
|
467,100
|
$10,963,000 | — | 31 Mar 2017 | |
| PointState Capital LP |
13F
|
Company |
1.6%
|
453,500
|
$10,644,000 | — | 31 Mar 2017 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
1.5%
|
437,822
|
$10,276,000 | — | 31 Mar 2017 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
1.4%
|
398,997
|
$9,364,000 | — | 31 Mar 2017 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
1.2%
|
345,945
|
$8,120,000 | — | 31 Mar 2017 | |
| BARCLAYS PLC |
13F
|
Company |
1.1%
|
322,301
|
$7,564,000 | — | 31 Mar 2017 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
1.1%
|
313,746
|
$4,124,000 | — | 31 Mar 2017 | |
| CASTLEARK MANAGEMENT LLC |
13F
|
Company |
1.1%
|
306,760
|
$7,200,000 | — | 31 Mar 2017 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
1.1%
|
306,422
|
$7,192,000 | — | 31 Mar 2017 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
1%
|
295,376
|
$6,932,000 | — | 31 Mar 2017 | |
| HARVEY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.98%
|
285,050
|
$6,690,000 | — | 31 Mar 2017 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.96%
|
280,242
|
$6,577,000 | — | 31 Mar 2017 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.95%
|
276,642
|
$6,493,000 | — | 31 Mar 2017 | |
| Legal & General Group Plc |
13F
|
Company |
0.92%
|
268,311
|
$6,303,000 | — | 31 Mar 2017 |
Institutional Holders of NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR) as of Q2 2017
As of 30 Jun 2017,
NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR) was held by
196 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
151,352,082 shares.
The largest 10 holders included
OppenheimerFunds, Inc., PRIMECAP MANAGEMENT CO/CA/, BlackRock Inc., VANGUARD GROUP INC, Camber Capital Management LLC, STATE STREET CORP, WESTFIELD CAPITAL MANAGEMENT CO LP, Invesco Ltd., BRIDGER MANAGEMENT, LLC, and NORGES BANK.
This page lists
196
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2017 vs Q1 2017 Across Filers
Q1 2017 holders
198
Q2 2017 holders
196
Holder diff
-2
| Investor | Q1 2017 Shares | Q2 2017 Shares | Share Diff | Share Chg % | Q1 2017 Value $ | Q2 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.